Scientific presentations

5

Nov 2023
20:16 E.S.T.

TGFBR2 KO combined with activation-induced IL12 secretion synergize to optimize potency and safety of MUC1-CAR T-cells in preclinical targeting of triple-negative breast cancer – SITC 2023 – Poster Presentation

Download the PDF file

27

Oct 2023
08:41 E.S.T.

Comprehensive Analysis of the Editing Window of TALE Base Editors – ESGCT 2023 – Poster Presentation

Download the PDF file

27

Oct 2023
08:38 E.S.T.

Intronic editing enables lineage-specific expression of therapeutics relevant for HSPC gene therapy – ESGCT 2023 – Poster presentation

Download the PDF file

27

Oct 2023
08:34 E.S.T.

Non-Viral DNA Delivery Coupled To TALEN Gene Editing Efficiently Correct The Sickle Cell Mutation In Long-Term HSCS – ESGCT 2023 – Poster Presentation

Download the PDF file

22

Sep 2023
13:06 E.S.T.

TALEN®-Edited Inducible Dual Car T-Cells Aimed at Safe and Effective Targeting Of Solid Tumors – CICON 2023 – Poster Presentation

Download the PDF file

8

Jun 2023
08:21 E.S.T.

Updated Results of the Phase I BALLI-01 Trial of UCART22, an Anti-CD22 Allogeneic CAR T-cell Product, in Patients with Relapsed or Refractory (R/R) CD22+ B-Cell Acute Lymphoblastic Leukemia (B-ALL) – EHA 2023 – Poster Presentation

Download the PDF file

5

Jun 2023
10:53 E.S.T.

UCART20x22: allogeneic dual CAR T-cells for the treatment of B-cell malignancies – ISCT 2023 – Oral Presentation

Download the PDF file

5

Jun 2023
07:29 E.S.T.

Comprehensive Analysis of the Editing Window of TALE Base Editors ISCT 2023 – Poster Presentation

Download the PDF file

5

Jun 2023
07:27 E.S.T.

Non-viral DNA delivery associated to TALEN® gene editing leads to highly efficient correction of sickle cell mutation in long-term repopulating hematopoietic stem cells  - ISCT 2023 – Poster Presentation

Download the PDF file

17

May 2023
22:55 E.S.T.

Expanding the Scope of Multiplex Engineering for Superior Generation of Efficient CAR T-cells – ASGCT 2023 – Poster Presentation

Download the PDF file

Scientific presentations

TGFBR2 KO combined with activation-induced IL12 secretion synergize to optimize potency and safety of MUC1-CAR T-cells in preclinical targeting of triple-negative breast cancer – SITC 2023 – Poster Presentation

Comprehensive Analysis of the Editing Window of TALE Base Editors – ESGCT 2023 – Poster Presentation

Intronic editing enables lineage-specific expression of therapeutics relevant for HSPC gene therapy – ESGCT 2023 – Poster presentation

Non-Viral DNA Delivery Coupled To TALEN Gene Editing Efficiently Correct The Sickle Cell Mutation In Long-Term HSCS – ESGCT 2023 – Poster Presentation

TALEN®-Edited Inducible Dual Car T-Cells Aimed at Safe and Effective Targeting Of Solid Tumors – CICON 2023 – Poster Presentation

Updated Results of the Phase I BALLI-01 Trial of UCART22, an Anti-CD22 Allogeneic CAR T-cell Product, in Patients with Relapsed or Refractory (R/R) CD22+ B-Cell Acute Lymphoblastic Leukemia (B-ALL) – EHA 2023 – Poster Presentation

UCART20x22: allogeneic dual CAR T-cells for the treatment of B-cell malignancies – ISCT 2023 – Oral Presentation

Comprehensive Analysis of the Editing Window of TALE Base Editors ISCT 2023 – Poster Presentation

Non-viral DNA delivery associated to TALEN® gene editing leads to highly efficient correction of sickle cell mutation in long-term repopulating hematopoietic stem cells - ISCT 2023 – Poster Presentation

Expanding the Scope of Multiplex Engineering for Superior Generation of Efficient CAR T-cells – ASGCT 2023 – Poster Presentation

Scientific publications

Non-viral DNA delivery associated to TALEN® gene editing leads to highly efficient correction of sickle cell mutation in long-term repopulating hematopoietic stem cells  - ISCT 2023 – Poster Presentation